0001| HOUSE BILL 306
|
0002| 43rd legislature - STATE OF NEW MEXICO - first session, 1997
|
0003| INTRODUCED BY
|
0004| FRED LUNA
|
0005|
|
0006|
|
0007|
|
0008|
|
0009|
|
0010| AN ACT
|
0011| RELATED TO OPTOMETRY; BROADENING THE DEFINITION OF THE PRACTICE
|
0012| OF OPTOMETRY; PERMITTING LASER SURGERY AND THE PRESCRIBING AND
|
0013| ADMINISTERING OF CERTAIN MEDICATIONS BY OPTOMETRISTS.
|
0014|
|
0015| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
|
0016| Section 1. Section 61-2-2 NMSA 1978 (being Laws 1973,
|
0017| Chapter 353, Section 2, as amended) is amended to read:
|
0018| "61-2-2. DEFINITIONS.--As used in the Optometry Act:
|
0019| A. "practice of optometry" means:
|
0020| (1) the employment of any subjective or
|
0021| objective means or methods, including the prescription or
|
0022| administration of topical ocular pharmaceutical agents, for the
|
0023| purpose of determining the visual defects or abnormal
|
0024| conditions of the human eye and its adnexa; and
|
0025| (2) the employing, adapting or prescribing of
|
0001| preventive or corrective measures by any means, including
|
0002| low vision rehabilitation, orthoptics, vision therapy,
|
0003| lenses, prisms, contact or corneal lenses or other optical
|
0004| appliances; refractive and therapeutic laser surgery
|
0005| procedures of the anterior segment of the eye; and prescribing
|
0006| or administering topical ocular pharmaceutical agents and oral
|
0007| pharmaceutical agents as authorized in Section 61-2-10.2 NMSA
|
0008| 1978 for the correction, relief or referral of visual defects
|
0009| or abnormal conditions of the human eye and its adnexa. The
|
0010| "practice of optometry" shall include the procedures and
|
0011| methods as taught by an accredited school or college of
|
0012| optometry, if the optometrist is qualified to do so by having
|
0013| passed the instruction and has been credentialed to perform the
|
0014| procedure or method by the board of optometric examiners, and
|
0015| shall not include the use of incisional surgery [or
|
injections in the treatment of eye diseases; provided].
|
0017| Persons who sell or dispense eyeglasses upon prescription and
|
0018| who do not prescribe ophthalmic lenses for the eyes shall not
|
0019| employ, adapt, dispense, modify, provide, sell, give or fit
|
0020| contact or corneal lenses; and provided further, the testing,
|
0021| design, dispensing and monitoring of a contact lens fitting
|
0022| shall be performed at the optometrist's place of practice;
|
0023| B. "ophthalmic lens" means a lens that has a
|
0024| spherical, cylindrical or prismatic value and that is ground
|
0025| pursuant to a prescription and intended to be used as
|
0001| eyeglasses or spectacles;
|
0002| C. "contact or corneal lens" means any lens to be
|
0003| worn on the anterior segment of the human eye, to be
|
0004| prescribed, dispensed, adapted, employed, modified, provided,
|
0005| sold and fitted by a licensed optometrist or physician;
|
0006| D. "prescription" means a formula written for
|
0007| ophthalmic lenses, for a topical ocular pharmaceutical agent or
|
0008| for an oral pharmaceutical agent as authorized in Section
|
0009| 61-2-10.2 NMSA 1978 that comes under the provisions of the New
|
0010| Mexico Drug, Device and Cosmetic Act by a person duly licensed
|
0011| and containing the following essential elements:
|
0012| (1) an order given individually for the person
|
0013| for whom prescribed, either directly from the prescriber to the
|
0014| pharmacist or indirectly by means of a written order signed by
|
0015| the prescriber, [and shall bear] that bears the name and
|
0016| address of the prescriber, his license classification, the name
|
0017| and address of the patient, the name and quantity of the drug
|
0018| prescribed, directions for use and the date of issue; or
|
0019| (2) dioptric power of spheres, cylinders and
|
0020| prisms, axes of cylinders, position of prism base and, if so
|
0021| desired by the prescriber, light transmission properties and
|
0022| lens curve values;
|
0023| (3) designation of pupillary distance; and
|
0024| (4) name of patient, date of prescription,
|
0025| expiration date and the name and office location of prescriber;
|
0001| provided, however, that:
|
0002| (5) those who sell and dispense eyeglasses
|
0003| upon the written prescription of a physician, surgeon or
|
0004| optometrist may determine the:
|
0005| (a) type, form, size and shape of
|
0006| ophthalmic lenses;
|
0007| (b) placement of optical centers for
|
0008| distance-seeing and near-work;
|
0009| (c) designation of type and placement of
|
0010| reading segments in multivision lenses;
|
0011| (d) type and quality of frame or
|
0012| mounting, type of bridge and distance between lenses, type,
|
0013| length and angling of temples; and
|
0014| (e) designation of pupillary distance;
|
0015| E. "eyeglasses" means any exterior optical device
|
0016| using ophthalmic lenses for the correction or relief of
|
0017| disturbances in and anomalies of human vision and includes
|
0018| spectacles and other devices using ophthalmic lenses; and
|
0019| F. "board" means the board of optometry."
|
0020| Section 2. Section 61-2-10.2 NMSA 1978 (being Laws 1995,
|
0021| Chapter 20, Section 5, as amended) is amended to read:
|
0022| "61-2-10.2. DESIGNATION OF ORAL PHARMACEUTICAL AGENTS--
|
0023| CERTIFICATION FOR USE OF CERTAIN AGENTS.--
|
0024| A. Subject to the provisions of the Optometry
|
0025| Act, optometrists qualified and certified by the board may
|
0001| prescribe or administer the following classes of oral
|
0002| pharmaceutical agents:
|
0003| (1) anti-infective medications, not
|
0004| including antifungals;
|
0005| (2) anti-glaucoma medications, not
|
0006| including osmotic medications;
|
0007| (3) anti-allergy medications;
|
0008| (4) anti-inflammatory medications [not
|
including oral corticosteroids and immunosuppression
|
agents]; and
|
0011| (5) analgesic medications, including
|
0012| schedules III through V controlled substances, as provided in
|
0013| the Controlled Substances Act.
|
0014| B. The board shall issue certification for the
|
0015| use of oral pharmaceutical agents as set forth in Subsection
|
0016| A of this section to optometrists currently licensed by the
|
0017| board who are certified for the use of topical ocular
|
0018| pharmaceutical agents. To be certified, an optometrist shall
|
0019| submit to the board proof of having satisfactorily completed
|
0020| a course in pharmacology as applied to optometry, with
|
0021| particular emphasis on the administration of oral
|
0022| pharmaceutical agents, including corticosteroids and
|
0023| immunosuppression agents, for the purpose of examination of
|
0024| the human eye, and analysis of ocular functions and treatment
|
0025| of visual defects or abnormal conditions of the human eye and
|
0001| its adnexa. The course shall constitute a minimum of twenty
|
0002| hours of instruction in clinical pharmacology, including
|
0003| systemic pharmacology as applied to optometry, and shall be
|
0004| taught by an accredited institution approved by the board.
|
0005| C. As of July 1, 1996, all applicants for
|
0006| licensure shall meet the requirements for certification in
|
0007| the use of diagnostic, topical therapeutic and oral
|
0008| pharmaceutical agents as set forth in the Optometry Act and
|
0009| shall successfully complete the board's examination in
|
0010| diagnostic, topical and oral pharmaceutical agents prior to
|
0011| licensure.
|
0012| D. The certification authorized by this section
|
0013| shall be displayed in a conspicuous place in the
|
0014| optometrist's principal office or place of business."
|
0015| - 6 -
|
0016|
|
0017|
|
0018|
|
0019|
|
0020|
|
0021|
|
0022|
|
0023|
|
0024| State of New Mexico
|
0025| House of Representatives
|
0001|
|
0002| FORTY-THIRD LEGISLATURE
|
0003| FIRST SESSION, 1997
|
0004|
|
0005|
|
0006| February 6, 1997
|
0007|
|
0008|
|
0009| Mr. Speaker:
|
0010|
|
0011| Your BUSINESS AND INDUSTRY COMMITTEE, to whom
|
0012| has been referred
|
0013|
|
0014| HOUSE BILL 306
|
0015|
|
0016| has had it under consideration and reports same with
|
0017| recommendation that it DO PASS, and thence referred to
|
0018| the CONSUMER AND PUBLIC AFFAIRS COMMITTEE.
|
0019|
|
0020| Respectfully submitted,
|
0021|
|
0022|
|
0023|
|
0024|
|
0025|
|
0001| Fred Luna, Chairman
|
0002|
|
0003|
|
0004| Adopted Not Adopted
|
0005|
|
0006| (Chief Clerk) (Chief Clerk)
|
0007|
|
0008| Date
|
0009|
|
0010| The roll call vote was 11 For 0 Against
|
0011| Yes: 11
|
0012| Excused: Alwin, Varela
|
0013| Absent: None
|
0014|
|
0015|
|
0016| G:\BILLTEXT\BILLW_97\H0306 State of New Mexico
|
0017| House of Representatives
|
0018|
|
0019| FORTY-THIRD LEGISLATURE
|
0020| FIRST SESSION, 1997
|
0021|
|
0022|
|
0023| February 18, 1997
|
0024|
|
0025|
|
0001| Mr. Speaker:
|
0002|
|
0003| Your CONSUMER AND PUBLIC AFFAIRS COMMITTEE,
|
0004| to whom has been referred
|
0005|
|
0006| HOUSE BILL 306
|
0007|
|
0008| has had it under consideration and reports same with
|
0009| recommendation that it DO PASS, amended as follows:
|
0010|
|
0011| 1. On page 1, line 22, following the word "ocular"
|
0012| insert "and certain oral".
|
0013|
|
0014| 2. On page 2, line 1, strike "by any means".
|
0015|
|
0016| 3. On page 2, strike all of the underscored language on
|
0017| lines 4 and 5 and insert in lieu thereof:
|
0018|
|
0019| "laser posterior capsulotomy; laser trabeculoplasty; laser
|
0020| iridotomy; laser iridoplasty; photorefractive keratectomy;
|
0021| phototherapeutic keratectomy; subcutaneous injections;
|
0022| subconjunctival injections; subtenons injections;".
|
0023|
|
0024| 4. On page 2, line 7, insert a comma following "agents".
|
0025|
|
0001| 5. On page 2, line 7, insert a comma following "1978".
|
0002|
|
0003| 6. On page 2, strike all the underscored language on
|
0004| lines 10 through 14.
|
0005|
|
0006| 7. On page 2, line 16, before the period insert:
|
0007|
|
0008| ", intraocular injections and retrobulbar injections. No
|
0009| optometrist shall administer an injection in the eye or perform
|
0010| laser posterior capsulotomy; laser trabeculoplasty; laser
|
0011| iridotomy; laser iridoplasty; photorefractive keratectomy;
|
0012| phototherapeutic keratectomy; subcutaneous injections;
|
0013| subconjunctival injections; subtenons injections, unless
|
0014| credentialed to do so by the board. The applicant must submit
|
0015| to the board certification that they have completed training in
|
0016| the procedures and methods taught by an accredited school or
|
0017| college of optometry".
|
0018|
|
0019| Respectfully submitted,
|
0020|
|
0021|
|
0022|
|
0023|
|
0024|
|
0025| Gary King, Chairman
|
0001|
|
0002|
|
0003| Adopted Not Adopted
|
0004|
|
0005| (Chief Clerk) (Chief Clerk)
|
0006|
|
0007| Date
|
0008|
|
0009| The roll call vote was 5 For 3 Against
|
0010| Yes: 5
|
0011| No: Heaton, Sandel, King
|
0012| Excused: Rios, Vigil
|
0013| Absent: None
|
0014|
|
0015|
|
0016| 117426.1
|
0017| G:\BILLTEXT\BILLW_97\H0306
|